U.S. markets closed

908 Devices Inc. (MASS)

NasdaqGM - NasdaqGM Precio en tiempo real. Divisa en USD.
Añadir a la lista de seguimiento
6.85-0.03 (-0.44%)
Al cierre: 04:00PM EDT
6.94 +0.09 (+1.31%)
Fuera de horario: 06:53PM EDT

908 Devices Inc.

645 Summer Street
Boston, MA 02210
United States
857 254 1500
https://908devices.com

Sector(es)Healthcare
IndustriaMedical Devices
Empleados a tiempo completo230

Ejecutivos clave

NombreTítuloPagarEjecutadoAño de nacimiento
Dr. Kevin J. Knopp Ph.D.Co-Founder, CEO, President & Director761.12kN/D1973
Mr. Joseph H. Griffith IVCFO & Treasurer491.89kN/D1975
Mr. Michael S. Turner Esq., J.D.Chief Legal & Administrative Officer and Secretary470.65kN/D1967
Dr. Christopher David Brown Ph.D.Co-Founder, Chief Product Officer & Co-Chair of Scientific Advisory Board459.7kN/D1975
Mr. Steve AraizaCo-FounderN/DN/DN/D
Mr. Andrew BartfayCo-Founder & Director of Hardware DevelopmentN/DN/DN/D
Mr. Michael JobinCo-Founder & Director of Product DevelopmentN/DN/DN/D
Dr. Scott Miller Ph.D.Co-Founder & Director of MS EngineeringN/DN/DN/D
Ms. Barbara RussoVice President of Marketing & Corporate CommunicationsN/DN/D1963
Mr. Don OsmerVice President of Human ResourcesN/DN/D1966
Los importes son a partir de 31 de diciembre de 2023 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Pago corresponde al salario, las bonificaciones, etc. Ejecutado corresponde al valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling. Its products also comprise Maven and Trace C2, an online device for bioprocess monitoring and control; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. The company operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of the Americas. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.

Gestión corporativa

La calificación ISS Governance QuickScore de 908 Devices Inc. a partir del 1 de mayo de 2024 es 10. Las puntuaciones principales son Auditoría: 8; Junta: 7; Derechos del accionista: 8; Compensación: 10.

Las puntuaciones de la gestión corporativa son cortesía de Servicios de accionistas institucionales (ISS). Las puntuaciones indican una posición decil en relación con el índice o la región. Una puntuación decil 1 indica que el riesgo de gestión es menor, mientras que una puntuación decil 10 indica que el riesgo de gestión es mayor.